Lenalidomide 20 mg/1 (Lenalidomide CAPSULE) 20 mg/1

Lenalidomide 20 mg capsules are a medication used to treat certain types of cancer and blood disorders. This oral medication is manufactured by Teva Pharmaceuticals, Inc. in the USA.

Strength

20 mg/1

Pack Size

21 CAPSULE in 1 BOTTLE (0480-1245-21)

Manufacturer / TM Owner

Teva Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lenalidomide is primarily used in the treatment of multiple myeloma and myelodysplastic syndromes. It works by helping the immune system to fight against cancer cells. This medication is often prescribed in combination with dexamethasone for better results. Lenalidomide capsules are taken orally and are designed to target specific cells in the body.

Side Effects

Common effects of Lenalidomide may include fatigue, diarrhea, and constipation. Some users may experience skin rash or muscle cramps. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Lenalidomide should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions. Pregnant women should avoid handling this medication due to potential risks. Always consult a healthcare provider before starting or stopping any medication.

Avoid Interactions

Lenalidomide may interact with certain medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of Lenalidomide.

Frequently Asked Questions

Lenalidomide is used to treat multiple myeloma and myelodysplastic syndromes by helping the immune system fight cancer cells.

Lenalidomide is taken orally, typically in capsule form, as prescribed by a healthcare provider.

Common side effects may include fatigue, diarrhea, constipation, and skin rash.

It is important to consult a healthcare provider before taking Lenalidomide with other medications to avoid potential interactions.

Lenalidomide should be avoided during pregnancy due to potential risks. Pregnant women should consult a healthcare provider before handling this medication.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.